8-K: Yield10 Bioscience Grants Global License to Vision Bioenergy for Herbicide Tolerant Camelina

Yield10 Bioscience has granted Vision Bioenergy Oilseeds an exclusive global license for its herbicide-tolerant Camelina technology for biofuel production, with a potential $3 million in payments to Yield10.

Summary

• Yield10 Bioscience has entered into a license and service agreement with Vision Bioenergy Oilseeds, granting Vision an exclusive global license for Yield10's herbicide-tolerant Camelina technology for biofuel production for three years, after which the license becomes non-exclusive.
• Vision will make cash payments to Yield10 totaling $3 million for the license and completion of certain deliverables.
• Yield10 will provide Vision with specific Camelina varieties, including those with herbicide tolerance, and technical assistance.
• The agreement aims to facilitate large-scale commercial production of Camelina for biofuel feedstock, supporting the decarbonization of various transport industries.
• Yield10 retains the right to sublicense the Camelina traits and varieties for other uses, such as omega-3 oil production.
• Vision plans to sample the herbicide tolerance system with key growers in 2024 and build seed supply for a potential commercial launch in 2025.

Sentiment

Score: 8

Explanation: The document is positive due to the significant licensing agreement, potential revenue, and validation of Yield10's technology. The partnership with Vision and Shell is also a strong positive. However, the exclusivity period is limited and there are risks associated with commercialization.

Positives

• The agreement provides Yield10 with a $3 million cash payment and potential future revenue through sublicensing.
• The license agreement allows Yield10 to scale its Camelina technology in the biofuel market through a partnership with Vision.
• The agreement validates Yield10's herbicide-tolerant Camelina technology and its potential for commercialization.
• The partnership with Vision, backed by Shell, provides a strong path to market for Yield10's technology.
• The agreement supports the growing demand for low-carbon intensity feedstock oil for biofuels.

Negatives

• The license is exclusive for only three years, after which it becomes non-exclusive, potentially reducing Yield10's future revenue potential from this specific application.
• Yield10's ability to benefit from the agreement is dependent on Vision's success in commercializing the technology.

Risks

• Yield10's ability to continue operations is dependent on securing adequate funding.
• The commercial launch of Camelina crops is subject to regulatory approvals and market adoption.
• The success of the agreement depends on Vision's ability to scale up production and deliver feedstock oil.
• There are risks associated with the integration of Camelina with current weed control and crop rotation practices.

Future Outlook

Yield10 plans to intensify its commercial focus on the development of engineered Camelina as a platform for producing and commercializing omega-3 oils, building on their recent successful scale up of the omega-3 Camelina line EPA8 in Chile. They also plan to pursue future partnership or licensing agreements for their advanced trait technologies as the scale of production grows.

Management Comments

• Don Panter, CEO of VISION, stated that acquiring the rights and access to seed will enable them to accelerate their commercial activities.
• Oliver Peoples, Ph.D, CEO of Yield10 Bioscience, believes that the license with Vision provides a path to scale and market their Camelina technology in biofuels.
• Oliver Peoples, Ph.D, CEO of Yield10 Bioscience, stated that they believe this is the best way to enable the value chain for Camelina as a valuable crop at very large scale.

Industry Context

This agreement aligns with the growing industry trend of developing sustainable biofuel feedstocks and the increasing demand for low-carbon intensity fuels. The partnership between Yield10 and Vision, backed by Shell, highlights the importance of collaboration between agricultural bioscience companies and energy companies in the renewable fuels sector.

Comparison to Industry Standards

• The development of herbicide-tolerant Camelina is a significant step in the biofuel feedstock industry, as it addresses a key challenge in large-scale production.
• Other companies, such as Corteva and Bayer, have also invested in herbicide-tolerant crops, but Yield10's focus on Camelina for biofuel is a unique approach.
• The partnership with Vision, which includes Shell, is comparable to other collaborations between agricultural and energy companies to develop sustainable fuel sources.
• The $3 million payment for the license is a significant milestone for Yield10 and demonstrates the value of their technology.

Stakeholder Impact

• Shareholders will benefit from the potential revenue and growth opportunities.
• Farmers will have access to herbicide-tolerant Camelina, potentially increasing their profitability.
• The agreement supports the development of sustainable biofuels, benefiting the environment and society.
• Employees of both Yield10 and Vision will be involved in the commercialization of the technology.

Next Steps

• Vision will sample the herbicide tolerance system with key growers in 2024.
• Vision will build planting seed supply to support a potential commercial launch in 2025.
• Yield10 will continue to develop engineered Camelina for omega-3 oil production.
• Yield10 will pursue future partnership or licensing agreements for their advanced trait technologies.

Key Dates

Keywords

Camelina, Biofuel, Herbicide Tolerance, License Agreement, Vision Bioenergy Oilseeds, Yield10 Bioscience, Feedstock, Oilseed, Renewable Diesel, Sustainable Aviation Fuel